ABSTRACT
Background and Objectives Non-alcoholic Fatty Liver Disease (NAFLD) is a common disorder with a complex etiology. Polymorphic variant rs738409 (Ile148Met) in the PNPLA3 gene has been reported to be associated with NAFLD among several ethnic populations. The present study aims to identify the potential association of this PNPLA3 gene variant with NAFLD among the ethnic Bengali population of West Bengal and correlate it with disease severity and biochemical parameters.
Materials and Methods The Ile148Met variant was genotyped among 99 clinically diagnosed NAFLD cases and 100 ethnicity-matched controls from West Bengal using PCR-RFLP-based techniques.
Results We identify statistically significant differences in genotype and allele frequencies of rs738409 between NAFLD cases and controls (P = 0.001 & 0.0057). The frequency distribution of risk genotype (GG) and risk allele (G allele) was significantly associated with a higher FIB-4 score (P = 0.0251) and Controlled Attenuation Parameter (CAP) score (P = 0.0072) but not with Liver Stiffness Measurement (LSM) value. The mean CAP score was significantly higher among the risk allele (G allele) carrier than the ‘C’ allele carrier (272.49±51.99 vs 247.38±49.46; P = 0.0328). In patients with NAFLD, the CC genotype was associated with a higher level of total bilirubin (P = 0.0189).
Conclusion The Ile148Met variant of the PNPLA3 gene is a predisposing risk factor for the development of NAFLD and is associated with increased severity of hepatic steatosis among the ethnic Bengali population of West Bengal.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Supported by grants from the Department of Biotechnology, Ministry of Science & Technology, Govt. of India (BT/NIDAN/01/05/2018) and Institutional Research Promotion, Nil Ratan Sircar Medical College, Govt. of West Bengal.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All procedures performed in studies involving human participants were in accordance with the ethical standards of the Nil Ratan Sircar Medical College & Hospital, Kolkata, India. The Ethics Committees (Institutional Ethics Committee, Nil Ratan Sircar Medical College & Hospital) of the abovementioned Institutes approved the study protocol. Informed consent was taken as per guidelines of the Indian Council of Medical Research, National Ethical guidelines for Biomedical and Health research involving human participants, India.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability Statement
The data described in this study are available from the corresponding author upon reasonable request.
